News from generex biotechnology corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 07, 2014, 09:30 ET

Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today responded to a recent article posted to the Seeking Alpha website...

Sep 30, 2014, 09:30 ET

Generex Announces Engagement of Dr. Lakshmi P. Kotra for Buccal Insulin Enhancement Project

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has engaged Dr. Lakshmi P. Kotra, B. Pharm.(Hons), Ph.D.,...

Sep 22, 2014, 09:30 ET

Generex Collaborates with University Health Network for Buccal Insulin Project

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has entered into a collaboration with University Health...

Sep 03, 2014, 09:15 ET

Generex / Antigen Express to Participate in BioPharm America™ 2014

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express,...

Aug 06, 2014, 09:30 ET

Generex Announces Publication of AE37 Prostate Cancer Vaccine Study

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of a follow-up study from a Phase I clinical...

Jun 17, 2014, 09:30 ET

Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation

Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced the posting of an interview given by Dr. Eric von Hofe, Ph.D.,...

Jun 12, 2014, 09:30 ET

Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced an interview given by Dr. Elizabeth Mittendorf, M.D., Ph.D....

Jun 10, 2014, 09:30 ET

Generex / Antigen Express to Participate in 2014 BIO International Convention

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc....

May 20, 2014, 09:30 ET

Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced two upcoming presentations demonstrating that certain patients...

Apr 23, 2014, 09:30 ET

Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that two abstracts in respect of results of the on-going...

Mar 27, 2014, 09:30 ET

Generex Announces $2,075,000 Capital Investment

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that it entered into a securities purchase agreement with...

Mar 26, 2014, 09:30 ET

Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that Dr. Eric von Hofe, Ph.D., the President of its wholly-owned...

Mar 05, 2014, 09:30 ET

Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that its wholly-owned subsidiary, Antigen Express, Inc....

Feb 27, 2014, 09:30 ET

Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of studies examining potential biomarkers...

Feb 12, 2014, 09:30 ET

Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial

Generex Biotechnology Corporation (www.generex.com) (GNBT) today announced that recent results from a Phase II study of a novel cancer vaccine...

Feb 04, 2014, 11:32 ET

Generex/Antigen Express "Stock News Now" Interview Available Online

Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that an interview of Dr. Eric von Hofe, PhD, President of the...

Jan 13, 2014, 09:30 ET

Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced completion of enrollment of the Antigen Express, Inc....

Jan 09, 2014, 09:30 ET

Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that Dr. Eric von Hofe, PhD, President of the Company's...

Jan 06, 2014, 09:00 ET

Generex/Antigen Express Announce Database Lock of AE37 Breast Cancer Vaccine Trial

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced the database lock for the primary efficacy analysis of its ongoing...

Nov 18, 2013, 09:00 ET

Antigen Express AE37 Breast Cancer Vaccine Update

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that it has reached a pre-specified point in the ongoing...